Medications

Nasal spray approved for treating suicidal people

Johnson & Johnson's Spravato has been approved as the first antidepressant for actively suicidal people, as doctors are becoming increasingly concerned about COVID-19's effect on the mental health of Americans.

Psychology & Psychiatry

Once-taboo ketamine booms for US at-home mental care

Americans are paying to get a star of the psychedelic medicine movement—ketamine—shipped to them for at-home mental health treatments that are being called both a breakthrough and a gamble.

page 1 from 30